Health and Healthcare

Amgen : AMGN

All Amgen Articles

699 Articles

Jon C. Ogg | Apr 2, 2014 at 3:37 PM EDT

Biotech Giants Now Priced Like Old World Drug Stocks

Jon OggMost investors buying Big Pharma stocks these days are buying them for dividends and somewhat of a defensive position…

Jon C. Ogg | Apr 2, 2014 at 8:20 AM EDT

Large Cap Biotechs Trading With Only Big Pharma P/E Ratios

In a new report from RBC, its analysts say that biotech stocks trading at some of the lowest forward multiples…

Jon C. Ogg | Mar 27, 2014 at 8:55 AM EDT

Morgan Stanley Starts Mixed Coverage on Top Biotech Stocks

courtesy of Morgan StanleyLike many of its Wall Street peers, the brutal sell-off in the biotechnology space has Morgan Stanley…

Jon C. Ogg | Mar 27, 2014 at 8:40 AM EDT

Top Analyst Upgrades and Downgrades: Apple, BlackBerry, Chesapeake, Citigroup, King Digital and More

These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Thursday, March 27, 2014.…

Trey Thoelcke | Mar 26, 2014 at 7:25 AM EDT

Short Sellers Find Renewed Interest in Biotech Stocks

After retreating from many leading biotech and emerging pharmaceutical stocks in the previous two periods, short sellers returned in early…

Trey Thoelcke | Mar 24, 2014 at 9:55 AM EDT

Top Biotechnology Stocks On Sale Again

For the second time in less than a month, the biotechnology sector got whacked when once again, chatter coming from…

Trey Thoelcke | Mar 14, 2014 at 8:50 AM EDT

Jefferies’ Cheapest Health Care Stocks to Buy

In a new report out from Jefferies, the analysts posted a complete list of the cheapest, on a P/E basis,…

Trey Thoelcke | Mar 13, 2014 at 9:15 AM EDT

Deutsche Bank’s Eight True Dividend Growth Stocks to Buy Now

In a new research report from Deutsche Bank, the equity strategists point that the companies that are maintaining and increasing…

Trey Thoelcke | Mar 12, 2014 at 9:00 AM EDT

Low P/E High-Dividend Blue Chip Leaders to Buy Now

The pricier the stock market gets, the more important it is for investors to keep a close eye on what…

Trey Thoelcke | Mar 12, 2014 at 7:10 AM EDT

Short Sellers Retreat From Biotech Stocks Again

Biotech and emerging pharmaceutical stocks continue to be hot, but short sellers shied away from many of them in late…

Trey Thoelcke | Feb 27, 2014 at 7:00 AM EST

Short Sellers Return to Biotech Stocks

After largely shying away in the previous period, short sellers returned to many of the leading biotech and emerging pharmaceutical…

Trey Thoelcke | Feb 12, 2014 at 6:50 AM EST

Short Sellers Shy Away From Biotechs

24/7 Wall St. has tracked the short interest in leading biotech and emerging pharmaceutical stocks. By and large, short sellers…

Paul Ausick | Feb 5, 2014 at 8:20 AM EST

Merck Earnings Fail to Dazzle, but the Company’s Story Remains Strong

Before the markets opened Wednesday morning, drug giant Merck & Co. reported fourth-quarter and full-year 2013 results that failed to…

cgblaine22 | Jan 29, 2014 at 12:10 PM EST

Why Caution Is Prevailing in Biotechs Into and After Earnings

Biogen Idec surprised investors Wednesday with weaker-than-expected guidance for 2014 earnings. Amgen beat estimates late Tuesday. Celgene and Gilead Sciences…

Trey Thoelcke | Jan 29, 2014 at 8:15 AM EST

UBS Says Buy Top Biotech Stocks in Front of Earnings for Big Upside

Like many firms on Wall Street, the biotechnology team at UBS thinks that most of the top mega-cap and large…

1 … 29 30 31 32 33 … 47

Amgen : AMGN

All Amgen Articles

Biotech Giants Now Priced Like Old World Drug Stocks

Large Cap Biotechs Trading With Only Big Pharma P/E Ratios

Morgan Stanley Starts Mixed Coverage on Top Biotech Stocks

Top Analyst Upgrades and Downgrades: Apple, BlackBerry, Chesapeake, Citigroup, King Digital and More

Short Sellers Find Renewed Interest in Biotech Stocks

Top Biotechnology Stocks On Sale Again

Jefferies’ Cheapest Health Care Stocks to Buy

Deutsche Bank’s Eight True Dividend Growth Stocks to Buy Now

Low P/E High-Dividend Blue Chip Leaders to Buy Now

Short Sellers Retreat From Biotech Stocks Again

Short Sellers Return to Biotech Stocks

Short Sellers Shy Away From Biotechs

Merck Earnings Fail to Dazzle, but the Company’s Story Remains Strong

Why Caution Is Prevailing in Biotechs Into and After Earnings

UBS Says Buy Top Biotech Stocks in Front of Earnings for Big Upside

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Amgen : AMGN

All Amgen Articles

Biotech Giants Now Priced Like Old World Drug Stocks

Large Cap Biotechs Trading With Only Big Pharma P/E Ratios

Morgan Stanley Starts Mixed Coverage on Top Biotech Stocks

Top Analyst Upgrades and Downgrades: Apple, BlackBerry, Chesapeake, Citigroup, King Digital and More

Short Sellers Find Renewed Interest in Biotech Stocks

Top Biotechnology Stocks On Sale Again

Jefferies’ Cheapest Health Care Stocks to Buy

Deutsche Bank’s Eight True Dividend Growth Stocks to Buy Now

Low P/E High-Dividend Blue Chip Leaders to Buy Now

Short Sellers Retreat From Biotech Stocks Again

Short Sellers Return to Biotech Stocks

Short Sellers Shy Away From Biotechs

Merck Earnings Fail to Dazzle, but the Company’s Story Remains Strong

Why Caution Is Prevailing in Biotechs Into and After Earnings

UBS Says Buy Top Biotech Stocks in Front of Earnings for Big Upside

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

Featured Reads

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%